BCOR and lung carcinoid tumor: reported a case of a 68-year-old with a history of lung carcinoid tumor who developed a suprasellar lesion, in which key mutations in PTCH1 and BCOR that have been previously implicated in both systemic neuroendocrine and primary pituitary tumors with potentially actionable therapeutic targets (17).